Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Imperial Oil | 2.25% | $4.82M | $46.38B | 29.52% | 74 Outperform | |
| Itochu | 2.21% | $4.74M | ¥13.68T | 25.50% | 70 Outperform | |
| Singtel | 2.17% | $4.65M | S$76.42B | 49.27% | 70 Outperform | |
| Next plc | 2.16% | $4.63M | £16.61B | 47.25% | 75 Outperform | |
| GlaxoSmithKline | 2.16% | $4.62M | £71.07B | 26.84% | 77 Outperform | |
| Prudential | 2.15% | $4.61M | £27.19B | 67.91% | 70 Outperform | |
| Pan Pacific International Holdings | 2.09% | $4.48M | ¥3.14T | 25.44% | 66 Neutral | |
| Poste Italiane SPA | 2.09% | $4.47M | €26.98B | 57.10% | 69 Neutral | |
| Great-West Lifeco | 2.08% | $4.45M | C$55.13B | 23.04% | 76 Outperform | |
| AstraZeneca | 2.08% | $4.45M | £199.98B | 31.46% | 76 Outperform |